COMPENSATION OF NAMED EXECUTIVE OFFICERS
EX-10.25 2 dex1025.htm SUMMARY OF COMPENSATION ARRANGEMENTS Summary of compensation arrangements
Exhibit 10.25
COMPENSATION OF NAMED EXECUTIVE OFFICERS
| Name and Position | Fiscal 2007 Base Salary ($) | Fiscal 2008 Base Salary ($) | Fiscal 2007 Bonus ($) | |||
| Peter D. Meldrum President and Chief Executive Officer | 676,500 | 727,000 | 550,000 | |||
| Gregory C. Critchfield, M.D. President, Myriad Genetic Laboratories, Inc. | 465,000 | 500,000 | 350,000 | |||
| Adrian N. Hobden, Ph.D. President, Myriad Pharmaceuticals, Inc. | 465,000 | 500,000 | 300,000 | |||
| Jay M. Moyes Chief Financial Officer | 355,000 | 380,000 | 220,000 | |||
| Mark H. Skolnick, Ph.D. (1) Chief Scientific Officer | 480,600 | 500,000 | 150,000 |
| (1) | Dr. Skolnick is compensated on an hourly basis. Base salary information reflects an annualized salary based on 2080 hours worked in a fiscal year. Actual amounts paid to Dr. Skolnick may vary significantly depending on the actual number of hours worked. |
